Clinical Trials

    Showing 1 - 2 of 2 pulmonary fibrosis

    A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)

    Status: Enrolling

    Investigator: Sandeep Sahay

    Study Coordinator: Rosa Barrosa da Costa

    Phone: 713.441.5660

    Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.... Read more >

    Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry (IPF/ILD-PRO)

    Status: Enrolling

    Investigator: Zeenat Safdar

    Study Coordinator: Jennifer Lee

    Phone: 713.363.7537

    This registry will collect data on the strategies used to achieve a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) and Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype (ILD) and the treatment and management efforts applied thr... Read more >